Does the M184V resistance mutation in reverse transcriptase reduce HIV transmission?

被引：2
|
作者：
Turner, D. [1 ]
机构：
[1] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Crusaid Kobler AIDS Ctr,Infect Dis Unit, IL-69978 Tel Aviv, Israel
来源：
HIV MEDICINE | 2011年 / 12卷 / 04期
关键词：
INFECTION; VARIANTS;
D O I：
10.1111/j.1468-1293.2010.00883.x
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：193 / 194
页数：2
相关论文
共 50 条
  • [1] Reverse transcriptase M184V resistance mutation: back to the future?
    Teyssou, E.
    Soulie, C.
    Palich, R.
    Nouchi, A.
    Abdi, B.
    Katlama, C.
    Wirden, M.
    Pourcher, V.
    Marcelin, A.
    Calvez, V.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 196 - 197
  • [2] Transmission dynamics of the M184V drug resistance mutation in primary HIV infection
    Wainberg, Mark A.
    Moisi, Daniela
    Oliveira, Maureen
    Toni, Thomas D'Aquin
    Brenner, Bluma G.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (10) : 2346 - 2349
  • [3] Decreased rates of transmission of drug-resistant HIV-1 strains containing the M184V mutation in reverse transcriptase
    Turner, D
    Brenner, BG
    Routy, JP
    Moisi, D
    Wainberg, MA
    ANTIVIRAL THERAPY, 2003, 8 (03) : U123 - U124
  • [4] Multiple effects of the M184V resistance mutation in the reverse transcriptase of human immunodeficiency virus type 1
    Turner, D
    Brenner, B
    Wainberg, MA
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2003, 10 (06) : 979 - 981
  • [5] Negative effect of the M184V mutation in HIV-1 reverse transcriptase on initiation of viral DNA synthesis
    Wei, X
    Liang, C
    Götte, M
    Wainberg, MA
    VIROLOGY, 2003, 311 (01) : 202 - 212
  • [6] Virulence and reduced fitness of simian immunodeficiency virus with the M184V mutation in reverse transcriptase
    Van Rompay, KKA
    Matthews, TB
    Higgins, J
    Canfield, DR
    Tarara, RP
    Wainberg, MA
    Schinazi, RF
    Pedersen, NC
    North, TW
    JOURNAL OF VIROLOGY, 2002, 76 (12) : 6083 - 6092
  • [7] The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors
    Miller, V
    Stürmer, M
    Staszewski, S
    Gröschel, B
    Hertogs, K
    de Béthune, MP
    Pauwels, R
    Harrigan, PR
    Bloor, S
    Kemp, SD
    Larder, BA
    AIDS, 1998, 12 (07) : 705 - 712
  • [8] Molecular impact of the M184V mutation in human immunodeficiency virus type 1 reverse transcriptase
    Diallo, K
    Götte, M
    Wainberg, MA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (11) : 3377 - 3383
  • [9] The impact of the HIV reverse transcriptase M184V mutation in combination with single thymidine analogue mutations on nucleoside reverse transcriptase inhibitor resistance in clinical samples from a large patient database
    Ross, L
    Parkin, N
    Bates, M
    Fisher, R
    St Clair, M
    Tisdale, M
    Lanier, R
    ANTIVIRAL THERAPY, 2003, 8 (03) : U134 - U135
  • [10] The M184V mutation in HIV-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses
    Wei, X
    Liang, C
    Götte, M
    Wainberg, MA
    AIDS, 2002, 16 (18) : 2391 - 2398
12345